Panama currently reports a pregnant women living with hiv antiretroviral therapy coverage for pmtct of 74%, a decrease of 10% (-11.9%) from 2021.
Pregnant women living with HIV antiretroviral therapy coverage for PMTCT in Panama
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,975
Measure:
%
More indicators for Panama
Male unintentional poisoning
0.4
+0.2
(2021)
Female wasting in children
0.9%
-0.5%
(2019)
Female prevalence of HIV
0.2%
0%
(2022)
Out-of-pocket expenditure PPP per capita
intl dollar1,237
+intl dollar91
(2022)
Birth registration
96.7%
+1.1%
(2019)
Contraceptive modern method prevalence
46.9%
-13.4%
(2015)
Panama PMTCT antiretroviral therapy coverage between 2000 and 2022
| Period | Value | Change |
|---|---|---|
| 2022 | 74% | -10% |
| 2021 | 84% | +21% |
| 2020 | 63% | -2% |
| 2019 | 65% | -9% |
| 2018 | 74% | -6% |
| 2017 | 80% | +5% |
| 2016 | 75% | -7% |
| 2015 | 82% | +7% |
| 2014 | 75% | -13% |
| 2013 | 88% | +12% |
| 2012 | 76% | -2% |
| 2011 | 78% | +10% |
| 2010 | 68% | 0% |
| 2009 | 68% | +5% |
| 2008 | 63% | +21% |
| 2007 | 42% | -15% |
| 2006 | 57% | -2% |
| 2005 | 59% | +35% |
| 2004 | 24% | -2% |
| 2003 | 26% | -1% |
| 2002 | 27% | +4% |
| 2001 | 23% | +7% |
| 2000 | 16% |